Not Yet RecruitingNot Applicable

Cohort Study of Chronic Liver Disease Complicated by Sepsis

1,600 participantsStarted 2026-02-25

Plain-language summary

Study population: Patients with liver cirrhosis complicated by sepsis Observation indicators: Fluid resuscitation strategy, early dynamic indicators such as MAP Observation endpoint: 28-day all-cause mortality Study design: Retrospective cohort study

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Clinically or pathologically diagnosed with cirrhosis; * meets the Sepsis-3 diagnostic criteria. Exclusion Criteria: * Combined organ transplantation, active malignant tumors; * Pregnant or breastfeeding women; * Long-term use of immunosuppressants (non-steroidal); * Death or voluntary discharge within 24 hours of admission; * Incomplete data.

What they're measuring

28-day all-cause mortality in cirrhosis with sepsis

Timeframe: Baseline and 28 days.

Trial details

NCT IDNCT07465003

SponsorThe Second Affiliated Hospital of Chongqing Medical University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2027-02-25

Contact for this trial

Li ShiYing Deputy Chief Physician of the Department of Infectious Disease, Ph.D

0086+18623322462 302946@hospital.cqmu.edu.cn

View on ClinicalTrials.gov More Cirrhosis trials